Eli Lilly said in a release that distributing the vials through the site will ensure patients and health-care providers are receiving "genuine" Zepbound
K., Kerr, G., Kremer, J., Nakamura, M
Research on GLP-1 adherence shows that patients who maintain consistent weekly schedules lose 15-22% of body weight over six months, while those with irregular dosing patterns lose only 8-12%
Jay Bregman, the founder and CEO, is a serial entrepreneur with 20+ years of experience building and scaling companies across mobility, insurance, and healthcare
While GLP-1 drugs promote fat loss, rapid weight reduction can lead to 1525% lean muscle mass loss